Valuation: EDAP TMS S.A.

Market Cap 192M 165M 154M 141M 266M 18.31B 268M 1.82B 708M 9.24B 721M 706M 30.6B P/E 2026 *
-3.22x
P/E 2027 * -5.35x
Enterprise Value 192M 165M 154M 141M 266M 18.31B 268M 1.82B 708M 9.24B 721M 706M 30.6B EV / Sales 2026 *
3.69x
EV / Sales 2027 * 2.66x
Free-Float
32.85%
Yield 2026 *
-
Yield 2027 * -
1 day+5.15%
1 week+3.17%
Current month-28.18%
1 month-28.53%
3 months+1.97%
6 months-4.25%
Current year+33.59%
1 week 4.01
Extreme 4.01
4.49
1 month 4.01
Extreme 4.01
6.4
Current year 3.1
Extreme 3.1
6.4
1 year 1.37
Extreme 1.37
6.4
3 years 1.21
Extreme 1.21
8.5
5 years 1.21
Extreme 1.21
12.65
10 years 1.21
Extreme 1.21
12.65
Manager TitleAgeSince
Chief Executive Officer 64 2023-04-30
Director of Finance/CFO 55 2023-12-31
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 64 2023-07-31
Chairman 64 2024-08-31
Director/Board Member 62 2024-07-07
Date Insider Type Main position Quantity % Market Cap.
8/14/26 Buy

Chief Financial Officer

5,000 0.0133%
8/14/26 Buy

Director

10,000 0.0267%
8/14/26 Buy

Chairman

50,000 0.1334%
Change 5-day change 1-year change 3-year change Capi.($)
+5.15%+3.17%+220.81%-46.01% 192M
-0.34%+6.42%+27.74%+15.75% 232B
+0.14%+7.86%+3.63%-15.76% 151B
-0.23%-4.91%-20.59%+25.01% 132B
+1.80%-1.39%-52.65%-1.95% 71.03B
-1.71%+0.61%-16.49%-12.61% 52.46B
+0.12%-0.46%+12.00%+18.89% 52.16B
+0.94%+4.23%+29.85%+29.27% 43.33B
+0.81%+3.21%+38.53%+51.49% 40.36B
-0.24%+1.90%-0.78%+7.90% 33.51B
Average +0.66%+1.23%+24.20%+7.20% 80.87B
Weighted average by Cap. +0.05%+2.78%+3.91%+10.35%

Financials

2026 *2027 *
Net sales 52.05M 44.6M 41.79M 38.18M 72.05M 4.96B 72.76M 493M 192M 2.5B 195M 191M 8.29B 72.14M 61.82M 57.93M 52.91M 99.86M 6.88B 101M 683M 266M 3.47B 271M 265M 11.49B
Net income -50.9M -43.62M -40.87M -37.33M -70.45M -4.85B -71.15M -482M -188M -2.45B -191M -187M -8.11B -31.76M -27.22M -25.5M -23.29M -43.96M -3.03B -44.39M -301M -117M -1.53B -119M -117M -5.06B
Net Debt - -
Logo EDAP TMS S.A.
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
Employees
289
Date Price Change Volume
26-08-25 US$4.395 +5.15% 22,876
26-08-24 US$4.180 +1.21% 129,968
26-08-21 US$4.130 -2.59% 236,364
26-08-20 US$4.240 -2.75% 175,913
26-08-19 US$4.360 +2.35% 218,068
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
4.180USD
Average target price
8.600USD
Spread / Average Target
+105.74%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. FOCL Stock